| SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species M Moustaqil, E Ollivier, HP Chiu, S Van Tol, P Rudolffi-Soto, C Stevens, ... Emerging microbes & infections 10 (1), 178-195, 2021 | 199 | 2021 |
| Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants S Ikegame, MNA Siddiquey, CT Hung, G Haas, L Brambilla, KY Oguntuyo, ... Nature communications 12 (1), 4598, 2021 | 122 | 2021 |
| Role of immunoglobulin M and A antibodies in the neutralization of severe acute respiratory syndrome coronavirus 2 J Klingler, S Weiss, V Itri, X Liu, KY Oguntuyo, C Stevens, S Ikegame, ... The Journal of infectious diseases 223 (6), 957-970, 2021 | 102 | 2021 |
| Emergency response for evaluating SARS-CoV-2 immune status, seroprevalence and convalescent plasma in Argentina DS Ojeda, MM Gonzalez Lopez Ledesma, HM Pallarés, ... PLoS pathogens 17 (1), e1009161, 2021 | 80 | 2021 |
| Quantifying absolute neutralization titers against SARS-CoV-2 by a standardized virus neutralization assay allows for cross-cohort comparisons of COVID-19 sera KY Oguntuyo, CS Stevens, CT Hung, S Ikegame, JA Acklin, SS Kowdle, ... MBio 12 (1), 10.1128/mbio. 02492-20, 2021 | 73 | 2021 |
| In plain sight: the role of alpha-1-antitrypsin in COVID-19 pathogenesis and therapeutics. KY Oguntuyo, CS Stevens, MNA Siddiquey, RM Schilke, MD Woolard, ... BioRxiv, 2020 | 41* | 2020 |
| Modulating the transcriptional landscape of SARS-CoV-2 as an effective method for developing antiviral compounds DA Hoagland, DJB Clarke, R Møller, Y Han, L Yang, ML Wojciechowicz, ... Biorxiv, 2020.07. 12.199687, 2020 | 29 | 2020 |
| Dissecting ELANE neutropenia pathogenicity by human HSC gene editing S Rao, Y Yao, JS de Brito, Q Yao, AH Shen, RE Watkinson, AL Kennedy, ... Cell Stem Cell 28 (5), 833-845. e5, 2021 | 27 | 2021 |
| Proteases and variants: context matters for SARS-CoV-2 entry assays CS Stevens, KY Oguntuyo, B Lee Current opinion in virology 50, 49-58, 2021 | 26 | 2021 |
| Metagenomics-enabled reverse-genetics assembly and characterization of myotis bat morbillivirus S Ikegame, JC Carmichael, H Wells, RL Furler O’Brien, JA Acklin, ... Nature Microbiology, 1-15, 2023 | 20* | 2023 |
| SARS-CoV-2 proteases cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species and the search for … M Moustaqil, E Ollivier, HP Chiu, S Van Tol, P Rudolffi-Soto, C Stevens, ... Biorxiv, 2020.06. 05.135699, 2020 | 15 | 2020 |
| Quantifying Neutralizing Antibodies in Patients with COVID-19 by a Two-Variable Generalized Additive Model KT Liu, YN Gong, CG Huang, PN Huang, KY Yu, HC Lee, SC Lee, ... Msphere 7 (1), e00883-21, 2022 | 9 | 2022 |
| Nipah virus Bangladesh infection elicits organ-specific innate and inflammatory responses in the marmoset model CS Stevens, J Lowry, T Juelich, C Atkins, K Johnson, JK Smith, M Panis, ... The Journal of Infectious Diseases 228 (5), 604-614, 2023 | 4 | 2023 |
| Genome-wide transposon mutagenesis of paramyxoviruses reveals constraints on genomic plasticity S Ikegame, SM Beaty, C Stevens, T Won, A Park, D Sachs, P Hong, B Lee, ... PLoS pathogens 16 (10), e1008877, 2020 | 4 | 2020 |
| An in vitro experimental pipeline to characterize the epitope of a SARS-CoV-2 neutralizing antibody KE Atanasoff, L Brambilla, DC Adelsberg, S Kowdle, CS Stevens, ... Mbio 15 (1), e02477-23, 2024 | | 2024 |
| De novo antibody discovery in human blood from full-length single B cell transcriptomics and matching haplotyped-resolved germline assemblies J Beaulaurier, L Ly, JA Duty, C Tyer, C Stevens, C Hung, A Sookdeo, ... bioRxiv, 2024.03. 26.586834, 2024 | | 2024 |
| Single-Cell Transcriptome Analysis and Assembly of Immunoglobulins with Oxford Nanopore Sequencing after MMR Vaccination A Sookdeo, C Tyer, L Ly, A Duty, C Stevens, C Hung, J Beaulaurier, ... JOURNAL OF MOLECULAR DIAGNOSTICS 25 (11), S56-S56, 2023 | | 2023 |
| Structure guided mutagenesis of Henipavirus Receptor Binding Proteins reveals molecular determinants of receptor usage and antibody binding epitopes KY Oguntuyo, GD Haas, KD Azarm, CS Stevens, L Brambilla, SS Kowdle, ... bioRxiv, 2023.11. 22.568281, 2023 | | 2023 |
| An in vitro experimental pipeline to characterize the binding specificity of SARS-CoV-2 neutralizing antibodies (preprint) KE Atanasoff, L Brambilla, DC Adelsberg, SS Kowdle, CS Stevens, ... | | 2023 |
| Viruses Are the Best Cell Biologists: Viral Engineering to Deliver Gene Editing Tools and Interrogate SARS-CoV-2 Entry CS Stevens Icahn School of Medicine at Mount Sinai, 2023 | | 2023 |
